Nesta: Longitude Prize 2016

Antibiotic Resistance is one of the biggest challenges facing us today. Bacteria are evolving to become resistant to the antibiotics we have successfully used for decades to treat infections.

The Longitude Prize will reward a competitor that can develop a transformative point–of–care diagnostic test that will conserve antibiotics for future generations and revolutionise the delivery of global healthcare.

The test must be accurate, rapid, affordable, easy–to–use and available to anyone, anywhere in the world.

It will identify when antibiotics are needed and, if they are, which ones to use.


Longitude Prize is looking to help tackle the problem with a £10M prize fund (approx AUD $19M) for a diagnostic tool that can rule out antibiotic use or help identify an effective antibiotic to treat a patient.


Anyone of any age and any organisation may enter the competition as long as the Eligibility Criteria is met:

  • The team is able to demonstrate that in winning the Longitude Prize it would deliver direct economic growth or benefit or social benefit in the UK.
  • To demonstrate such benefit the team must include a member which has a presence in the United Kingdom, meaning an office in the UK, affiliation with a UK Company or partnership with a UK organisation or institution, and meet one of the following requirements:
    • carry out manufacturing and/or design of the winning solution in the UK, or
    • lab test or showcase the winning solutions in the UK, or
    • use some other means agreed in writing with Nesta and Innovate UK before participating in the Longitude Prize

Submission Requirements & Due Date

Applications are submitted directly to the Sponsor by 31 May 2016 (first assessment deadline)

Further Information

This entry was posted in Funding by Award Type, Health & Medical Sciences. Bookmark the permalink.

Comments are closed.